BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7428575)

  • 1. [Report on 13 cases (including 3 deaths) of liver damage induced by rifampicin (author's transl)].
    Tong YY
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):35-8. PubMed ID: 7428575
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of rifampicin-induced acute renal failure and review of 47 cases with liver dysfunction induced by isoniazid and rifampicin (author's transl)].
    Sugiyama Y; Kudo S; Kitamura S; Kosaka K
    Kekkaku; 1981 Jul; 56(7):375-8. PubMed ID: 7328998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver dysfunction induced by rifampicin (author's transl)].
    Kutsukake F; Murakami T; Sasaki Y; Mitani Y; Kamada T; Shigeto N; Yoshioka H; Sewake N; Fukuhara N; Shibata Y; Shigeto E; Tanaka K; Kadosawa K; Kou E; Mochizuki K
    Kekkaku; 1982 Apr; 57(4):257-61. PubMed ID: 7109426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis induced by combined rifomycin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
    Martinez-Roíg A; Camí J; Llorens-Terol J; de la Torre R; Perich F
    Pediatrics; 1986 Jun; 77(6):912-5. PubMed ID: 3487069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological and histochemical study of the liver during antituberculotic polychemotherapy in children ].
    Mihailovici MS
    Morphol Embryol (Bucur); 1987; 33(3):205-8. PubMed ID: 2958698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complications with rifampicin treatment: one case with anuria (author's transl)].
    Chevalier JP; Plantier J; Kofman J; Montagnon B; Magnin F; Perrin-Fayolle M; Traeger J
    Poumon Coeur; 1980; 36(4):287-91. PubMed ID: 7443620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual recurrence of antitubercular drug induced hepatotoxicity in a child.
    Bhatia S; Tullu MS; Kannan S; Gogtay NJ; Thatte UM; Lahiri KR
    J Postgrad Med; 2011; 57(2):147-52. PubMed ID: 21654145
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity of rifampicin and isoniazid in children.
    Casteels-Van Daele M; Igodt-Ameye L; Corbeel L; Eeckels R
    J Pediatr; 1975 May; 86(5):739-41. PubMed ID: 1079531
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.